Views of Wockhardt's Manufacturing Facilities As Indian Pharmaceuticals Breach Quality Control : News Photo

Views of Wockhardt's Manufacturing Facilities As Indian Pharmaceuticals Breach Quality Control

Credit: 
Bloomberg / Contributor
Women shelter their heads from the rain outside the Wockhardt Ltd. manufacturing facility in the Chikalthana industrial area in Aurangabad, India, on Monday, Sept. 16, 2013. Wockhardt currently controls about 26 percent of the U.S. market for metoprolol, a generic version of the heart pill sold by London-based AstraZeneca Plc under the brand name Toprol-XL, according to Needham & Co. Metoprolol alone makes up about 14 percent of the company's 56 billion rupees in annual revenue. Photographer: Dhiraj Singh/Bloomberg via Getty Images
Caption:
Women shelter their heads from the rain outside the Wockhardt Ltd. manufacturing facility in the Chikalthana industrial area in Aurangabad, India, on Monday, Sept. 16, 2013. Wockhardt currently controls about 26 percent of the U.S. market for metoprolol, a generic version of the heart pill sold by London-based AstraZeneca Plc under the brand name Toprol-XL, according to Needham & Co. Metoprolol alone makes up about 14 percent of the company's 56 billion rupees in annual revenue. Photographer: Dhiraj Singh/Bloomberg via Getty Images
Calculate priceView cart
Date created:
September 16, 2013
Editorial #:
181965090
Release info:
Not released.More information
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
License type:
Rights-managedRights-managed products are licensed with restrictions on usage, such as limitations on size, placement, duration of use and geographic distribution. You will be asked to submit information concerning your intended use of the product, which will determine the scope of usage rights granted.
Collection:
Bloomberg
Credit:
Bloomberg via Getty Images
Max file size:
4,000 x 2,667 px (20.00 x 13.34 in) - 200 dpi - 2.66 MB
Source:
Bloomberg
Object name:
INDIA WOCKHARDT

Keywords

This image is subject to copyright. Getty Images reserves the right to pursue unauthorized users of this image or clip, and to seek damages for copyright violations. To learn more about copyright and Getty Images’ enforcement program, click here. Availability for this image cannot be guaranteed until time of purchase.
Women shelter their heads from the rain outside the Wockhardt Ltd... News Photo 181965090Adult,Asia,Asian,Built Structure,Factory,Female,Finance,Geographical Locations,Head,Healthcare And Medicine,Horizontal,India,Indian,Indian Subcontinent,Indian Subcontinent Ethnicity,Industry,Maharashtra,Manufacturing,Medicine,Rain,Sheltering,WomenPhotographer Collection: Bloomberg 2013 BloombergWomen shelter their heads from the rain outside the Wockhardt Ltd. manufacturing facility in the Chikalthana industrial area in Aurangabad, India, on Monday, Sept. 16, 2013. Wockhardt currently controls about 26 percent of the U.S. market for metoprolol, a generic version of the heart pill sold by London-based AstraZeneca Plc under the brand name Toprol-XL, according to Needham & Co. Metoprolol alone makes up about 14 percent of the company's 56 billion rupees in annual revenue. Photographer: Dhiraj Singh/Bloomberg via Getty Images